Jefferies Bullish on ACHC: New Management to Drive Stability and Higher Profits
Jefferies upgraded ACHC to Buy, raised target to $30, citing better management, stability, and profit upside after strong gains.
Jefferies upgraded ACHC to Buy, raised target to $30, citing better management, stability, and profit upside after strong gains.
IREN will build a huge 800MW AI data center in South Australia, powered by clean energy, creating 500+ jobs by 2028.
Deal adds utility-scale BESS expertise and is expected to deliver $15–20M EBITDA in 2027.
Macy’s reported its strongest first quarter in years, with comparable sales up 3% and Bloomingdale’s surging 10.2%. The retailer raised its full-year 2026 sales and earnings guidance for the first time in nearly four years.
SpaceX is set to surprise investors with a fixed $135 IPO price, targeting a record $75 billion raise and a $1.75 trillion valuation. The roadshow starts Thursday.
Rezolute’s drug showed strong Phase 3 results, reducing IV glucose needs in rare tumor HI. Analysts raised targets and turned bullish.